Maria Ester Bernardo

SR Tiget, Milan

Update on the clinical trial results of HSC-gene therapy for mucopolysaccharidosis type 1 Hurler

Cesar Trigueros

Viralgen

AAV serotype associated impurities under a production platform.

Zoltan Ivics

Paul Ehrlich Institute, Langen

Non-viral engineering of therapeutic cells with the Sleeping Beauty transposon system

Juan Bueren

CIEMAT, Madrid

Cristian Smerdou

CIMA Universidad de Navarra, Pamplona

Towards the implementation of gene therapy in the clinical practice

Antonio Perez-Martinez

Hospital Universitario La Paz, Madrid

Cell therapy based on the Chimeric receptor NKG2D

Benedikt Berninger

Institute of Psychiatry, Psychology & Neuroscience Centre for Developmental Neurobiology & MRC Centre for Neurodevelopmental Disorders, King's College London

Advancing in vivo glia-to-neuron reprogramming as an innovative approach for brain repair: promises, disappointments, and breakthroughs

Jose Carlos Segovia

CIEMAT, Madrid

Lentiviral Mediated Gene Therapy for Pyruvate Kinase Deficiency

Simón Méndez-Ferrer

Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK

Targeting the stem cell niche in the myeloid malignancies

Fernando Larcher

Ciemat Madrid

Correction of recessive dystrophic epidermolysis bullosa using genome editing strategies

Manuel Mazo

Universidad de Navarra, Pamplona

Computational biomechanics, 3D printing and hiPSCs: towards the generation of a biological ventricular assist device

Carlos Fernandez de Larrea

IDIBAPS, Barcelona

CAR-T cells for the treatment of multiple myeloma

Alba Rodriguez

Hospital Clínic de Barcelona

Strategies to improve CAR-T cell therapy for solid tumors